The aim of this study is to measure baseline serum cortisol levels and clinical response to glucocorticoid therapy in a group of term infants with refractory hypotension.
The ability of the hypothalamic-pituitary-adrenal axis to respond to stress is critical for survival. Infants with congenital adrenal insufficiency develop cardiovascular collapse when they encounter stressful situations without appropriate steroid therapy. During the immediate newborn period, the adrenal gland undergoes complex changes to adapt to postnatal life and to maintain adequate cortisol production. A subset of newborn infants may have a delay in this adaptive process leading to transient hypoadrenalism. Recently, Helbock et al. 1 reported low plasma cortisol levels in a group of extremely low birth weight newborns who had severe hypotension refractory to volume expansion and inotropic drugs. Hypotension in all infants improved rapidly after administration of hydrocortisone and vasopressors could be discontinued. Although the pathophysiological mechanism was unclear, they concluded that this group of extremely low birth weight infants had glucocorticoid deficiency. Adrenal function of term infants has been studied using different stimuli. [2] [3] [4] Most full-term infants appear to have some degree of adrenal response to stress. However, Thomas et al. 5 performed adrenocorticotropin hormone (ACTH) tests in term newborns and found that a subset of ill infants had low cortisol levels (Ͻ5 g) despite their illness. The objectives of this study were to determine if a subset of term infants with refractory hypotension had low serum cortisol levels and to measure their clinical response to glucocorticoid therapy.
METHODS
The seven full-term newborns were admitted to the Neonatal Intensive Care Units at Children's Hospital of Los Angeles or Los Angeles County-University of Southern California Medical Center. Primary diagnoses were diaphragmatic hernia (2), meconium aspiration syndrome (3), meconium peritonitis (1), and hypoplastic left heart syndrome (1). All were acutely ill and ventilator-dependent. During their hospital course, all developed significant hypotension requiring multiple boluses of volume expanders and vasopressors. Arterial pressures were measured using indwelling peripheral or umbilical arterial catheters. When there were questions regarding the accuracy of direct pressure recording, it was compared with blood pressure measured by oscillometry. The heart rate, blood pressure, and doses of dopamine and dobutamine were recorded at baseline, then 4, 8, 12, 24, 48, 72 , and 96 hours after glucocorticoid therapy was started. Serum cortisol was drawn before initiation of glucocorticoid therapy and measured by either fluorescence polarization immunoassay (n ϭ 5) (TDx/ TDxFLx Cortisol assay; Abbott Laboratories, Abbott Park, IL) or radio- Table 1 summarizes the patients' characteristics. Their birth weight ranged from 2.4 to 3.9 kg and gestational age ranged from 37 to 41 weeks. Age of initiation of glucocorticoid therapy ranged from 1 to 9 days. All infants were ventilator-dependent and were massively edematous secondary to the volume resuscitation needed to maintain blood pressure. In 5 of 7 patients, echocardiograms were performed to assess cardiac function and demonstrated normal contractility at the time of initiation of glucocorticoid therapy. None of the patients were septic. Serum cortisol levels were done in six of seven patients. Cortisol levels ranged from 2.0 to 15.4 g/dl with five of six patients having levels less than 10 g/dl. They had received between 20 and 94 ml/kg of 5% albumin, or plasma for hypotension, and all were receiving dopamine (5 to 20 g/kg per min) and dobutamine (4 to 15 g/kg per min), with one infant additionally on epinephrine (0.4 g/kg per min). Table 2 shows mean blood pressure, heart rate, and the total of dopamine and dobutamine doses at baseline and after dexamethasone was started. Mean blood pressure significantly increased at 4 hours after initiation of dexamethasone therapy. At the same time, heart rate decreased significantly and remained significantly lower than baseline throughout the 96-hour period. The total dopamine and dobutamine doses were significantly decreased after 4 hours of dexamethasone therapy. Within 12 hours of dexamethasone therapy, total dopamine and dobutamine doses were decreased to less than 50% of baseline in all infants. Vasopressors were discontinued in all infants within 72 hours after dexamethasone therapy.
RESULTS
When comparing 24-hour periods before and after dexamethasone therapy, the requirement for volume resuscitation significantly decreased (64.4 Ϯ 9.7 vs 10.0 Ϯ 3.8 ml/kg, p Ͻ 0.001). However, urine output increased significantly (2.01 Ϯ 0.38 vs 4.50 Ϯ 0.82 ml/kg per hour, p Ͻ 0.05). In all infants the requirement for volume expanders decreased, and urine output improved in all but one (Figures 1 and 2 ). In three of seven patients, no volume expanders were required after initiation of steroids. No infants required any volume resuscitation after 2 days. All seven infants survived and none required extracorporeal membrane oxygenation (ECMO). None developed hyperglycemia requiring insulin therapy during steroid treatment. None of the infants developed clinically significant hypertension.
DISCUSSION
It has been suggested that glucocorticoids may have roles in treating hypotension in premature infants.
1 Also, glucocorticoids have been used in treating shock in adults. 6, 7 To our knowledge, this is the first report of clinical responses to dexamethasone therapy in full-term newborns with hypotension. These newborn infants required multiple volume expanders and inotropic agents to maintain their blood pressure. The blood pressure of these infants improved transiently during volume expander infusion; however, it gradually decreased after the volume infusion was stopped. The multiple volume infusions to maintain blood pressure contributed to generalized edema of these patients. The data presented in Table 2 showed that the mean blood pressure before dexamethasone therapy was 51 Ϯ 3 mm Hg, which could be considered normal for a newborn in the first week of life. However, it was foreseen that in order to keep the blood pressure within the acceptable range, more volume infusions, higher doses of inotropic agents, or, in some cases, ECMO were necessary. Dexamethasone therapy clearly stabilized these patients' clinical conditions. The blood pressure improved rapidly and became stable enabling weaning of vasopressors and volume expanders. Dexamethasone therapy also resulted in improvement in tachycardia and urine output. In some of these infants, ECMO had been set up in order to support cardiac output. Fortunately, ECMO was avoided after dexamethasone therapy and the rapid clinical improvement.
The mechanisms of glucocorticoids in stabilizing blood pressure are not completely understood. However, studies have shown that glucocorticoids are involved in blood pressure control in many ways. 8 -13 Glucocorticoids are also involved in cardiac contractility and vascular tone modulation. Animal studies have shown that glucocorticoids modulated cardiac mass and protein. 8, 9 In vitro, a low concentration of corticosteroid produces a positive inotropic effect whereas a high concentration elicits a negative inotropic action. 10 Glucocorticoid antagonist (RU 486) decreases vascular reactivity to norepinephrine and angiotensin II, whereas glucocorticoids reverse this process. 11 Steroids are able to inhibit inducible nitric oxide synthase, thus increase vascular tone and resistance. 12 It was also suggested that glucocorticoid action on blood pressure might be related to mineralocorticoid action. 13 Many studies have shown that newborn infants have significant adrenal response to stress such as venupuncture, 2 respiratory distress, 14 -16 minor surgery, 4,17,18 and major surgery. 3, 19 Contrarily, some studies report that term newborns have decreased response to stress (especially in an immediate newborn period) compared to older infants, 20 -23 and the authors suggested that some newborns might have relative adrenal hypofunction.
What is an adequate serum cortisol level in a stressed full-term newborn has not been defined, neither the correlation of serum cortisol levels and the newborn's clinical course and outcomes. The mean serum cortisol level of 11 ill term newborns in one study was 13.4 g/dl.
5 Mean cortisol levels after circumcision were between 17.2 and 19.3 g/dl 17, 18 and mean serum cortisol levels after cardiac surgery was 22.3 g/dl.
19 Infants in this study were exposed to multiple physical stress such as intubation, mechanical ventilation, respiratory distress, and multiple intravenous catheterization and in one case, surgery. We found that serum cortisol levels in our infants were relatively low compared to the cortisol levels reported in the stressed infants mentioned above. All but one infant had serum cortisol levels below 10 g/dl. Although, the significance of a single value of serum cortisol levels during stress in representing adrenal function has not been extensively tested, it has been used to indicate adrenal responsiveness by some authors. 7, 24, 25 Devins et al. 26 stated that plasma cortisol levels of less than 15 g/dl in critically ill patients suggest the presence of adrenal insufficiency. The fact that our infants in this study had relatively low serum cortisol levels and responded dramatically to dexamethasone therapy lead us to believe that these infants might be in the glucocorticoid deficiency state. It could be argued that the stabilization of the blood pressure was from pharmacological effects of dexamethasone. However, we felt that the dexamethasone dose we chose was low and probably close to physiological glucocorticoid production under stress. Cortisol production rate in normal newborn infants under 5 days of age have been estimated to be 1.22 Ϯ 0.22 mg/kg per day. 27 Under stress, it has been shown that cortisol production could be three to five times higher than baseline. 28 Based on these data, cortisol production rate in a stressed term newborn can be as high as 3.66 to 6.1 mg/kg per day, which is equivalent to a dexamethasone dose between 0.15 to 0.24 mg/kg per day. We chose dexamethasone in preference to hydrocortisone based on our observation that infants treated with hydrocortisone had a significantly higher incidence of fungal sepsis. 29 In our patients, there were no significant hyponatremia or hyperkalemia that can be found in classic adrenal insufficiency. Nevertheless, lack of these conditions does not exclude the possibility of glucocorticoid insufficiency. Normal electrolyte might suggest that mineralocorticoid function was still intact. Moreover, because all of these infants were very ill, they were given intravenous glucose continuously and serum glucose and electrolyte levels were closely monitored and maintained. Thus, clinical hypoglycemia, hyponatremia, and hypokalemia might not be apparent.
There are many possible reasons why some newborns may have inadequate adrenal response to stress. In animals, there is a postnatal window called the stress nonresponsive period (SNRP), during which they exhibit reduced capacity to secret ACTH and corticosterone in response to stress. 30 It was thought to be due to hypothalamic immaturity. Whether this condition exists in human newborns is unknown. Anesthesia has been shown to decrease the cortisol response to surgical stress. 17, 31 All of our infants in this report received some sedatives or analgesics. Dosages used were the usual recommended dosages (fentanyl, 1 to 2 g/kg per hour; lorazepam, 0.1 to 0.2 mg/kg per dose; diazepam, 0.1 to 0.2 mg/kg per dose; or phenobarbital, 5 mg/kg per day). Whether these drugs significantly affect the hypothalamicpituitary-adrenal response to stress is not known. During the immediate newborn period, the adrenal gland undergoes changes to adapt to postnatal life. 32 A large percentage of preterm newborns has been shown to have an inadequate adrenal response to low-dose ACTH (0.1 to 0.3 g/kg), 24, 33 which is thought to be due to immaturity of adrenal steroidogenesis. It is conceivable that some full-term infants may also have delayed maturation of adrenal steroidogenesis. Other reasons that could explain decreased adrenal response to stress include insufficient blood supply to adrenal glands secondary to hypotension, adrenal hemorrhage, and circulating substances, which can inhibit adrenal responsiveness to ACTH. 6 Although, we demonstrated clear benefits with no apparent significant side effects of dexamethasone therapy for blood pressure support in our infants, as an uncontrolled study with a small number of subjects, our study has limitations. Further controlled studies in larger population are needed to clarify the indications, risks, and benefits of glucocorticoid therapy for blood pressure support in newborn infants. Comparing clinical responses to dexamethasone with other glucocorticoids may determine whether the effects on stabilizing blood pressure are dexamethasone-specific. Moreover, the roles of glucocorticoid deficiency in sick full-term newborns need to be examined. Comparing serum cortisol levels in sick infants that have refractory hypotension with ones that are comparably sick but are normotensive or require less blood pressure support may clarify the significance of serum cortisol levels. Tests for corticotropin releasing factor stimulation or physiological ACTH stimulation test in the sick newborns may prove presence and reveal mechanisms of adrenal insufficiency.
CONCLUSIONS
We have demonstrated that dexamethasone therapy clearly improved blood pressure and stabilized clinical conditions of a group of full term newborns with refractory hypotension without apparent significant side effects. We also found that serum cortisol levels of these infants were relatively low despite physiological stress. We speculate that a subset of ill full-term newborns might be in a relative adrenal insufficiency state, which contribute to their hemodynamic instability. When dealing with full-term newborns who have refractory hypotension, work-up, and treatment with glucocorticoids for adrenal insufficiency should be considered.
